This is unpublished
Dr. Nora Disis. Photo: Cancer Vaccine Institute
Institute of Translational Health Sciences logo
April 4, 2022

ITHS Receives $63M in Research Funding

The Institute of Translational Health Sciences (ITHS) has been granted over $63 million in funding over the next five years through a Clinical and Translational Grant from the National Institutes of Health.
Scroll for more
arrow icon
Back to top

This will be the fourth Clinical and Translational Science Award (CTSA) that ITHS has received since its inception in 2007 as a partnership between the University of Washington, Fred Hutchinson Cancer Research Center, and Seattle Children’s.

“I am delighted to have the CTSA renewed for the next five years,” said Dr. Mary (Nora) Disis, professor (Medical Oncology), ITHS director and associate dean for translational science at the UW School of Medicine. “ITHS has made great strides in supporting clinical and translational research over the last five years with the formation of the UW Medicine’s Clinical Trials Office, the creation of numerous research networks across the WWAMI (Washington, Wyoming, Alaska, Montana, Idaho) region, and significantly increased resources for research on the electronic health record.”

The CTSA program is part of the National Center for Advancing Translational Science (NCATS). NCATS was established to fund a network of ‘hubs’ to help advance scientific discoveries by turning observations in the laboratory, clinic, and community into interventions that improve health; a field of investigation known as “translational science.” There are now 64 of these hubs across the nation.